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Abstract 
The evening chronotype is associated with psychological symptoms such as depressed mood, 
while skin exposure to ultraviolet radiation (UVR) may affect mood and behavior through 
neural and humoral routes. This pilot study aimed to investigate the impact of whole-body 
narrow-band (NB) UV-B exposure on current mood state and circulating 25-hydroxyvitamin 
D3 (25(OH)D3), interleukin-6 (IL-6), cortisol and β-endorphin (β-END) levels in healthy 
participants. Here, eleven healthy women received full-body NB UV-B exposures on four 
afternoons, and the chronotype was assessed with a shortened version of Horne and Östberg's 
Morningness-Eveningness Questionnaire (MEQ). Perceived mood was evaluated using the 
Visual Analogue Scale (VAS), and serum 25(OH)D3, IL-6, cortisol and β-END 
concentrations were monitored daily. Decreasing VAS values showed mood to improve 
significantly over the five days after the four suberythematous NB UV-B exposures 
(p=0.038), and the more the circadian preference was inclined towards eveningness, the 
greater the improvement in the mood dimension of wellbeing (p=0.021). Baseline mood state 
was correlated with baseline 25(OH)D3 (r = -0.54, 95% CI: -0.86 to -0.09) and with baseline 
cortisol (r = -0.57, 95% CI: -0.87 to -0.04). During the NB UV-B exposures, 25(OH)D3 
increased significantly, as expected, and IL-6 declined significantly by -0.35 (95% CI: -0.69 
to -0.07) pg/mL from the initial values of 1.12±0.66 pg/mL (p=0.025). In conclusion, in our 
pilot study, NB UV-B exposure improved mood, especially among those with evening 
preference for their daily activities, as well as circulating 25(OH)D3 levels, whereas 
circulating IL-6 levels decreased. 
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Introduction 
Chronotype is a measure of individual differences in daily activity patterns and sleep-wake 
cycles whereby humans can be classified into three chronotypes based on the timing of 
physiological functions and their preference in daily activities: morning types (advanced sleep 
period), neither types, and evening types (delayed sleep period) (Duffy et al. 2001; Horne and 
Östberg 1976). The chronotype has a genetic basis and is influenced by environmental factors 
such as latitude and photoperiod (Randler and Rahafar 2017; Shawa et al. 2018). Higher 
latitudes are characterized by greater seasonal variations in photoperiod, and people living at 
high latitudes seem to have a tendency towards a late time of day preference (Borisenkov et 
al. 2010; Leocadio-Miguel et al. 2017). Previous studies suggest that the preference for 
eveningness may be associated with depressive symptoms and mood disorders (Au and Reece 
2017; Hidalgo et al. 2009; Jeong Jeong et al. 2015; Merikanto et al. 2013). 
Circadian rhythms are present in near all tissues throughout the human body, and the 
circadian system is responsible for regulating the approximate 24-hour rhythms in biological 
(e.g., hormone levels), psychological (e.g., alertness and mood) and behavioral (e.g., eating, 
exercising and sleeping) variables (Adan et al. 2012; Dibner 2019; Lemmer 2009). The 
individual morningness-to-eveningness preferences arise from the differences in the 
endogenous circadian clock and the daily schedule for activities as well as the interplay 
between these two systems (Barclay et al. 2014; Dijk and von Schantz 2005; Kerkhof 1985). 
Circadian rhythms are generated and maintained by the intrinsic clocks to track time and 
correspond to the temporal organization of the environment. Light exposure is the most potent 
time cue for synchronizing internal circadian rhythms with the transitions of the external 
light-dark cycle (Münch and Bromundt 2012; Roenneberg et al. 2007; Zeitzer et al. 2005). 
Human skin is repeatedly exposed to solar ultraviolet radiation (UVR), a confirmed 
environmental carcinogen that induces mutations and simultaneous immunosuppression (Hart 
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and Norvall 2018; Murphy 2009; World Health Organization 2012). The ultraviolet B (UV-B) 
wavebands (315-280 nm) are biologically the most active part of the solar spectrum reaching 
the Earth, and UV-B-induced DNA damage leads to the release of various pro-inflammatory 
mediators from keratinocytes, including interleukin-6 (IL-6) (Hart and Norvall 2018; Murphy 
2009; Urbanski et al. 1990; World Health Organization 2012). In addition, UV-B radiation 
exerts strong biological actions on regulatory pathways related to immune balance, both 
vitamin-D-related and vitamin-D-independent (Skobowiat and Slominski 2015). 
UV-B radiation induces the cutaneous photosynthesis of vitamin D, which leads to increased 
levels of its circulating form, i.e., 25-hydroxyvitamin D3 (25(OH)D3). Vitamin D 
insufficiency (levels of 50–75 nmol/L) and deficiency (levels of <50 nmol/L) are common at 
high latitudes in winter unless vitamin D substitution is used (Holick 2007; Holick and Chen 
2008). Low 25(OH)D3 status has been linked to poorer mental health and may explain the low 
vitality, energy and mood observed in winter (Berk et al. 2007; Harris and Dawson-Hughes 
1993; Humble 2010; Jääskeläinen et al. 2015). 
IL-6 and cortisol are first-line immune modulators that can be synthesized in the skin under 
stress conditions, including UVR exposure, and delivered in the circulation (Kirnbauer et al. 
1991; Skobowiat et al. 2011; Skobowiat and Slominski 2015; Urbanski et al. 1990). Elevated 
IL-6 levels have been detected in patients presenting with major depressive disorder (Hodes et 
al. 2016; Liu et al. 2012), while cortisol has been associated with the immune system and 
mood (Shattuck and Muehlenbein 2015). Patients who did not respond and were resistant to 
antidepressant medications had increased circulating TNF-α and IL-6 levels and impaired 
cutaneous glucocorticoid receptor function (Fitzgerald et al. 2006). A large proportion of 
depressed patients showed excessive cortisol production (Carpenter and Gruen 1982). 
Beta-endorphin (β-END) is formed in the epidermal skin from proopiomelanocortin (POMC) 
upon UVR exposure (Fell et al. 2014; Skobowiat and Slominski 2015). Human studies of 
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UVR-induced β-END are rare, however, and the results are conflicting. In mice, UV-B-
induced β-END led to the development of UVR-addictive behavior, and it has been suggested 
that it may underlie tanning-dependent behavior in humans (Skobowiat and Slominski 2015). 
This pilot study investigated the impact of whole-body narrow-band (NB) UV-B exposure on 
the current mood state, in general and according to chronotype, in healthy participants and the 
associations with the circulating 25(OH)D3, IL-6, cortisol and β-END levels. We 
hypothesized that a) NB UV-B exposure improves the current mood state and that b) this 
improvement occurs through the skin-borne circulating mediators and is reflected in changes 
in their circulating levels. Further, we hypothesized that these changes are greater in 
individuals with an eveningness preference for daily activities because a) they tend to have a 
higher ratio of phase advancing to phase delaying of circadian rhythms by light exposure 
(Emens et al. 2009) and b) they appear to benefit from the phase advance accompanied by 
improvements in self-reported depression and stress (Facer-Childs et al. 2019). 
Materials and Methods 
The study was implemented at the Department of Dermatology and Venereology, Tampere 
University Hospital, Tampere, Finland, 61°N, in October to November, when the availability 
of biologically effective skin-burning UV-B solar ultraviolet radiation was negligible. The 
protocol followed the principles of the Declaration of Helsinki and its amendments and was 
approved by the Regional Ethics Committee of Tampere University Hospital District (# 
R14012). The volunteers were recruited through advertisements and provided informed 
consent. No compensation was given. 
Volunteers 
Twelve healthy women agreed to participate. The inclusion criteria were as follows: a) they 
had no phototherapy, solarium visits or sunny holidays during the preceding two months, and 
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b) they had taken no vitamin D supplements during the preceding two months. The volunteers 
had to regard themselves as “healthy” and have not had any psychiatric interventions. 
Depression was not specifically screened. The exclusion criteria were a) sun-sensitive 
Fitzpatrick skin phototype I, b) the use of antidepressants or any psychotropic drugs, c) the 
use of medication with definite photosensitizing potential (specifically, amiodarone, 
dacarbazine, doxycycline, phenothiazine, furosemide, diclofenac, NSAIDs, ketoprofen, and 
piroxicam) and d) pregnancy. We also asked whether the volunteer was using any medication, 
and if so, we asked them to name it. Demographic data were collected with respect to age, 
gender, skin phototype (Fitzpatrick 1988) and body-mass index (BMI). 
Narrow-band UV-B exposures 
The volunteers received four full-body NB UV-B exposures in the afternoons of four 
consecutive days. Their eyes were covered with opaque goggles during the irradiations. The 
irradiance of the Waldmann UV 7002 phototherapy cabin (Herbert Waldmann GmbH & Co. 
KG, Villingen-Schwenningen, Germany), which was equipped with 42 TL01 tubes (Schulze 
& Böhm GmbH, Brühl, Germany), was measured beforehand using an Ocean Optics S2000 
spectroradiometer (Ocean Optics, Inc., Largo, FL, USA). After correcting for systematic 
errors and stray light, it was estimated that the uncertainty (2σ) of the measurement was 
approximately 14%. These assessments were traceable to the National Institute of Standards 
and Technology (Gaithersburg, MD, USA). The initial NB UV-B physical dose was 0.17 
J/cm2, corresponding to one standard erythema dose (1 SED), which is equivalent to an 
erythemal effective radiant exposure of 10 mJ/cm2 (Commission Internationale de l’Éclairage 
1999). In the course of the four days, the dose was increased from 0.17 J/cm2 to 0.34 J/cm2 (2 
SED) for 5 volunteers and to 0.51 J/cm2 (3 SED) for 6 volunteers. The cumulative dose of the 
four irradiations thus ranged from 1.19 J/cm2 (7 SED) to 1.36 J/cm2 (8 SED). 
Evaluation of mood state 
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To determine whether the four NB UV-B exposures affected the participants’ mood state, 
they were asked to rate their mood on each day immediately before the scheduled NB UV-B 
exposure and on day five 24 hours after the last exposure, employing the Visual Analogue 
Scale (VAS), where values closer to zero depict better feelings (Folstein and Luria 1973). The 
eventual mood VAS used in the statistical analyses was the mean of four dimensions of 
mood, 1) VAS-satisfaction, 2) VAS-tiredness, 3) VAS-wellbeing and 4) VAS-irritation, each 
scored separately (in millimeters) on a 100-mm line with its ends anchored to the concepts of 
“best ever” versus “worst ever”. The questions above the VAS scales asked “How do you rate 
your feelings of satisfaction/tiredness/wellbeing/irritation at the moment?” 
Morningness-Eveningness Questionnaire (MEQ-6) 
A Morningness-Eveningness Questionnaire (MEQ-6, v.1.2 FI, National Institute for Health 
and Welfare, Helsinki, Finland) based on the original Horne & Östberg Morningness-
Eveningness (MEQ-19) questionnaire translated to Finnish was used to define the chronotype 
(Horne and Östberg 1976). The modified instrument comprises six questions. All the answers 
were scored and summed for the total Morningness-Eveningness score of 5 to 27 points. In 
our analyses, the participants were classified into morning or evening chronotypes (“Larks” 
vs. “Owls”) based on the last question in MEQ-6, where the definitely morning and rather 
morning than evening chronotypes were classified as “Larks”, and definitely evening and 
rather evening than morning chronotypes were classified as “Owls”. 
Time schedule for blood sampling 
Blood samples were taken prior to each NB UV-B exposure to measure circulating 
25(OH)D3, IL-6, cortisol and β-END levels. All samples were drawn at the same hour of the 
afternoon on five consecutive days. The first sample was taken on day 0 before the first 
exposure, and the last sample was taken 24 hours after the final NB UV-B exposure. The 
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blood samples were protected from the light and centrifuged, whereupon the sera were 
separated out and stored at -70°C until used for the analyses. 
Laboratory analyses 
25(OH)D3 was determined by a Chemiluminescent Microparticle Immunoassay using the 
Architect system (Abbott Laboratories, Abbott Park, IL, USA). Quality control was further 
ensured by participation in the International External Quality Assessment Scheme (DEQAS) 
(Miettinen et al. 2014). Due to the short duration of the trial, no nutritional analysis of the 
availability of vitamin D in the diet was performed, but the volunteers were asked to keep 
their diet constant during the experiment. 
Serum immunoreactive β-END was measured using an ELISA method developed at the 
University of Oulu, Finland. Samples and synthetic human beta-endorphin calibrators were 
incubated with synthetic beta-endorphin-containing C-terminal biotin and the rabbit anti-
human beta-endorphin antiserum “BK22” (Vuolteenaho 1984) at a final dilution of 1/100000. 
After overnight incubation at +4°C, streptavidin-horseradish peroxidase conjugate (Pierce, 
Thermo Fisher Scientific Inc., Waltham, MA, USA) was added, followed by 3,3',5,5'-
tetramethylbenzidine substrate (TMB One, KemEnTec Diagnostics A/S, Taastrup, Denmark). 
The reaction was stopped with 2-N sulfuric acid, and the wells were scanned at A450 nm with a 
Varioskan Flash Plate Reader (Thermo Scientific, Thermo Fisher Scientific Inc., Waltham, 
MA, USA). Serum cortisol was measured using a Ref 52611 ELISA kit from IBL 
International GmbH, Hamburg, Germany, and IL-6 was measured with a DY206 ELISA kit 
from R&D Systems, Inc., Minneapolis, MN, USA, according to the instructions provided by 
the manufacturers. 
Statistical analyses 
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We report the results as the means with standard error of mean (SEM) and 95% confidence 
intervals (CIs). Due to the sample size and some skewed distributions, resampling-based 
(Bootstrap or Monte-Carlo) methods were used in the analyses to define the significance level 
(p-value) and 95% CIs. Mean changes (within subjects) in mood and physiological 
biomarkers between day 5 and baseline values were assessed using the Fisher-Pitman 
permutation test for paired replicates (exact p-value). Changes on day 5 and baseline values 
between chronotypes were compared using bootstrap-type independent-sample t-tests (5000 
replications). Statistical significance for the hypothesis of linearity across the 5-day periods of 
biomarkers was tested using bootstrap-type repeated-measures analysis of variance 
(rANOVA). Effect size (d) was calculated using the method of Cohen, where an effect size of 
0.20 is considered small, 0.50 moderate, and 0.80 large; CIs for the effect sizes were obtained 
by bias-corrected bootstrapping (5000 replications). We used linear regression models to 
evaluate the contributions of the total Morningness-Eveningness score and the skin phototype 
as independent predictors of the dependent outcome of the change in VAS-wellbeing. We 
calculated the correlation coefficients using Spearman’s method. The normality of the 
variables was tested using the Kolmogorov-Smirnov test. No adjustment was made for 
multiple testing, but this information can be obtained by multiplying the actual p-value by the 
number of comparisons made. Statistical analyses were carried out using the Stata statistical 
software, release 14.1 (StataCorp, College Station, TX, USA), and the IBM Statistical 
Package for the Social Sciences (SPSS) Statistics, version 25 (International Business 
Machines Corporation, Armonk, NY, USA). 
Results 
Chronotype and other background characteristics 
Eleven of 12 women completed the experiment, since one withdrew for personal reasons. 
Five volunteers had a preference towards morningness (Larks) and six towards eveningness 
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(Owls). The mean age was 41.6 ±11.2 years. Eight volunteers (72.7%) displayed skin 
phototype II (often burns and tans poorly), and three (27.3%) displayed skin phototype III 
(sometimes burns and tans easily) (Fitzpatrick 1988). The mean BMI was 25.1± 5.1 kg/m2. 
Impact of NB UV-B exposures on mood 
The mean VAS score (VAS-mean) of the eleven participants on the four mood dimensions 
(satisfaction, tiredness, wellbeing and irritation) was 28.6±15.9 mm before the NB UV-B 
exposures, which improved between day 5 and baseline significantly by a mean of 7.4 (95% 
CI: -14.5 to -0.3) mm by the end of the study (p=0.038, Figure 1). The declining VAS-mean 
depicted improved mood in eight of eleven participants (73%), five of whom were Owls. The 
VAS-mean was higher (i.e., the mood was worse) in the Owls than in the Larks on each day. 
On the other hand, the VAS-mean decreased from baseline to day 5 in the Owls, 11.8 (95% 
CI: -21.4 to -2.2) mm, and the Larks, 2.1 (95% CI: -11.6 to 7.5) mm, i.e., the mood state 
improvement was larger in the Owls, but the difference between the groups was not 
statistically significant (p=0.19) (Figure 1 and Table 1). 
There was a difference in the change in the “VAS-wellbeing” mood dimension from baseline 
to day 5 between the Larks [1.0 (95% CI: -5.6 to 7.6)] and Owls [-16.8 (95% CI: -25.8 to -
5.8)] amounting to -17.8 (95% CI: -31.92 to -3.75) mm on average (p=0.019). Furthermore, in 
the regression analysis, the total Morningness-Eveningness score alone significantly 
explained the change in VAS-wellbeing (R2 = 0.47; B = -2.10, 95% CI: -3.80 to -0.40; 
p=0.021), whereas the skin phototype alone did not. However, the model (with R2 = 0.72), in 
which we entered both the total Morningness-Eveningness score (B = -2.54, 95% CI: -3.92 to 
-1.15; p=0.003) and the skin phototype (B = -15.34, 95% CI: -28.59 to -2.10; p=0.028), 
explained significantly the change in VAS-wellbeing, and showed greater improvement 
among the Owls and among those having skin phototype II. Adding age to this model (R2 = 
0.85) yielded similar results and pointed to the same two predictors as being significant. 
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Impact of UVR irradiations on circulating biomarkers 
The baseline 25(OH)D3 values ranged from 43 to 128 nmol/L, with two volunteers apparently 
being vitamin-D-deficient (below 50 nmol/L) and three displaying vitamin D insufficiency 
(levels 50-75 nmol/L) (Holick 2007; Holick and Chen 2008). The four NB UV-B whole-body 
exposures effectively improved the 25(OH)D3 levels of all 11 volunteers by 8.3 (95% CI: 5.6 
to 11.8) nmol/L from the initial values of 75.5 ± 28.0 nmol/L (p<0.001; effect size 1.50 (95% 
CI: 0.69 to 2.30)) (Figure 2a), and increases seemed detectable as early as after the first NB 
UV-B exposure. The increase was greatest in the volunteers with the lowest baseline values. 
None of the women were vitamin-D-deficient any longer by day five, but the five with the 
lowest baseline 25(OH)D3 levels remained vitamin-D-insufficient (Holick 2007; Holick and 
Chen 2008). 
The initial IL-6 values ranged from 0.34 to 2.21 pg/mL, showing a 7-fold interindividual 
variation, but the mean value seemed to decrease significantly by -0.35 (95% CI: -0.69 to -
0.07) pg/mL from the initial level of 1.12±0.66 pg/mL (p=0.025; effect size 0.54 (95% CI: 
0.09 to 1.31)) (Figure 2b). 
Baseline cortisol values varied from 243 to 526 nmol/L, and among volunteers, the mean 
level had increased by 79 (95% CI:-18 to 177) nmol/L from the initial level of 391±81 nmol/L 
following the NB UV-B irradiations (Figure 2c), although this difference was not statistically 
significant (p=0.16). 
The baseline β-END values showed a notable 45-fold interindividual variation, ranging from 
18 to 362 fmol/mL giving an initial mean of 203±129 fmol/mL. This increased by 39 (95% 
CI: -50 to 129) fmol/mL following the NB UV-B exposures, but the difference was not 
statistically significant (p=0.41). β-END increased in six volunteers and decreased in five 
volunteers over the five days of the experiment (Figure 2d). 
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The mean serum 25(OH)D3, β-END, cortisol and IL-6 levels on each day are shown by 
chronotype (Larks/Owls) in Table 1. The mean 25(OH)D3 levels were lower in the Owls 
throughout, as were the mean IL-6 levels. Mean β-END seemed higher in the Owls than in the 
Larks at the end of the study, but there was considerable overall fluctuation in both groups. 
Mean cortisol levels seemed to be higher in the Owls on each day (Table 1). 
Correlations between perceived mood and circulating biomarkers 
Although the volunteers’ baseline 25(OH)D3 levels correlated with the baseline mood state 
(VAS mm) (r = -0.54, 95% CI: -0.86 to -0.09, p=0.085), the improvement in 25(OH)D3 did 
not correlate with the improvement in mood state on day five (r= -0.14, 95% CI: -0.68 to 
0.50, p=0.66). 
The baseline IL-6 (pg/mL) values and perceived mood state (VAS mm) were not correlated (r 
= 0.06, 95% CI: -0.56 to 0.64, p=0.85), nor were the NB UV-B-induced increase in IL-6 and 
the improvement in mood (r = -0.44, 95% CI: -0.82 to 0.22, p=0.18), but the individual 
volunteers with higher baseline IL-6 clearly displayed a better mood state. 
The volunteers’ cortisol levels at baseline correlated with their mood state (r = -0.57, 95% CI: 
-0.87 to -0.04, p=0.065), but there was no correlation between the subsequent UVR-induced 
increase in cortisol and the improvement in the mood VAS result (r= -0.03, 95% CI: -0.62 to 
0.58, p=0.94). 
Initial β-END values and mood VAS were not correlated (r = 0.43, 95% CI: -0.23 to 0.82, 
p=0.18), nor was there any correlation between the increase detected in β-END and the 
improvement in mood VAS (r= -0.15, 95% CI: -0.69 to 0.49, p=0.65). 
Discussion 
Our findings suggest a relationship between NB UV-B exposure and the mood state of the 
volunteers, referring to the fact that the improvement in mood was greater in those with their 
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preference towards eveningness rather than morningness, the effect being significant for the 
change in the VAS-wellbeing dimension. NB UV-B significantly improved the balance of 
circulating vitamin D, and circulating IL-6 levels seemed to decrease. These findings suggest 
that further studies are required on the interactions between UVR, skin and mood. 
There is evidence of an association between chronotype and mood disorders, as those with a 
circadian preference favoring eveningness appear to be prone to depression (Au and Reece 
2017; Hidalgo et al. 2009; Jeong Jeong et al. 2015; Merikanto et al. 2013). In previous 
studies, mood assessments were used to evaluate depression or depressive symptoms over a 
longer period of time, e.g., during the past 12 months. In the present study, the volunteers 
who reported that they were evening chronotypes had a worse current mood state on average 
than the others throughout the five-day trial. The evening chronotypes also tended to show 
more improvement in their current mood state than the morning chronotypes following UVR 
exposure. However, because the participants in the current study were healthy, and as 
depression was not specifically screened and interviewed by us, any comparison between the 
current study and past research should be made with caution. To extend and deepen the scope 
of such generalizations, further studies need to be focused on volunteers with a current 
depressive episode, as assessed using a structured clinical interview for diagnosis, to elucidate 
the effects and mechanisms of action of NB UV-B exposures on mood. Future studies are 
required to show the possible causal relationship between depressive symptoms and evening 
chronotype and, further, whether it could be worthwhile trying NB UV-B phototherapy for 
people suffering from depressive symptoms or other mood disorders. 
The skin is capable of reacting to psychiatric and psychosocial conditions and is a potential 
source of numerous UVR-inducible neuroactive compounds (Denda et al. 2013; Slominski et 
al. 2012; Slominski and Wortsman 2000). We have shown earlier that NB UV-B exposure 
increases the expression of β-END in the human skin in vivo (Jussila et al. 2016), and mouse 
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experiments have shown UV-B exposure to be capable of inducing β-END expression in the 
skin even to the point of developing addictive behavior towards UV radiation (Fell et al. 
2014; Skobowiat and Slominski 2015). In the present study, the circulating β-END levels 
were increased during NB UV-B exposures, although not significantly, as there was up to 45-
fold interindividual variation in these levels. 
The present study demonstrated that the skin phototype together with the chronotype 
contributed significantly to the improvement in mood as assessed by means of scores on the 
subscale dimension of wellbeing on the VAS scales. The improvement was greater in the 
participants with skin phototype II than in those with skin phototype III. Phototype II burns 
more easily and tans less well than phototype III (Fitzpatrick 1988). Fair-skinned people are 
known to be more sensitive to the effects of UVR, which could explain the better mood-
enhancing property of the UV-B exposures in our study. It has been reported in an earlier 
review that UVR was found to be capable of improving mood in six out of seven existing 
studies (Veleva et al. 2018). An explanation here might be that NB UV-B exposure influences 
mood and behavior through, e.g., thermoregulation, which in depressed individuals is often 
disturbed. The tentative warming of the body during UV-B exposure might interfere with 
mood, as is shown for those with major depressive disorder, whereas warming with infrared 
light produces therapeutic benefits, which could occur through the deactivation of brown 
adipose tissue (Janssen et al. 2016). 
We found that vitamin D status was lower in those volunteers who reported that their daytime 
peak was mainly in the evening rather than in the morning. One earlier study has shown that 
evening types have unhealthier dietary habits and that they ingest less vitamin D than 
morning types (Kanerva et al. 2012). To test the hypothesis that NB UV-B-induced increases 
in circulating vitamin D levels are associated with improved mood, much further study is 
necessary. 
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Four NB UV-B exposures with low nonerythematous physiological dosing also induced a 
significant decrease in IL-6 levels, and we also noted that the volunteers with evening 
preference displayed lower IL-6 levels throughout the study than those with morning 
preference. In an earlier study, Mondin et al. (2016) discovered that healthy individuals with a 
reversed day/night schedule had decreased IL-6 levels. In contrast to our findings, Urbanski et 
al. (1990) showed an increase in IL-6 levels after broadband (BB) UV-B exposure, with a 
peak value at 12 hours, but the BB UV-B doses used were aggressively high. However, 
further studies are necessary to verify any connection between UV-B exposure-induced IL-6 
levels and mood. 
We detected that UV-B seemed to induce an increase in cortisol levels, although not to a 
significant extent in our pilot study, and the average cortisol levels were slightly higher in the 
evening types than in the morning types on each day. Both UV-B and UV-C wavelengths 
have been shown previously to elevate cortisol levels in the skin (Fitzgerald et al. 2006). In 
the case of our study, the taking of the blood samples in the afternoon instead of the morning 
may be reflected in a decreased response, and this should be taken into account in further 
studies. We did expect that the circulating mediators of the NB UV-B exposures we assessed 
would correlate with the perceived changes in the current mood state, but they did not show 
any correlation with mood. 
The limitations of our pilot study included the small number of volunteers, only female 
volunteers (since no men volunteered), and the lack of a control group. The groups of each 
chronotype were small, and some findings showed trends rather than reaching significance. 
Moreover, all the volunteers were healthy. 
Conclusions 
Our results indicate that four suberythematous exposures to NB UV-B can induce a change in 
perceived mood and 25(OH)D3 as well as IL-6 levels. Mood improved more in evening 
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chronotypes than morning chronotypes. Our findings support the hypothesis that UVR-
exposed human skin transmits cues via reciprocal molecular interactions that affect mood 
regulation in the brain and contribute to behavior and the timing of daily activities. However, 
the demonstration of the exact mechanisms remains a major challenge. 
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Figure 1. Perceived mood state immediately before NB UV-B irradiation on each day of 
the experiment and 24 hours after the last exposure. The bars depict the mean and SEM of 
the perceived mood of 11 participants on each day, taken all together (on the left, with gray 
bars), and by chronotype (Larks/Owls) (on the right, with white and black bars). The 
perceived mood state was evaluated as the mean of four dimensions of mood: 1) satisfaction, 
2) tiredness, 3) wellbeing and 4) irritation. Each dimension was assessed on a 100-mm VAS 
scale, where a smaller value depicted a better mood. 
  
Day
1 2 3 4 5
M
oo
d,
 V
AS
0
5
10
15
20
25
30
35
40
45
50
Day
1 2 3 4 5
All
Larks
Owls
 22 
 
 
 
 
Figure 2a-d. The bars (from left to right) depict the means and SEM of a) serum 
25(OH)D3 (nmol/L), b) IL-6 (pg/mL), c) cortisol (nmol/L), and d) β-END (fmol/mL) on 
each day of the experiment. All blood samples were drawn immediately before the NB UV-
B exposures or 24 hours after the last exposure. p-values show linearity across the 5-day 
periods. 
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Table 1. Mean serum vitamin D (25(OH)D3), β-END, cortisol and IL-6 levels and mood VAS 
of the participants, grouped by chronotype (Larks/Owls). 
 
  Baseline Day 2 Day 3 Day 4 Day 5 
“Larks”           
25(OH)D3 (nmol/L) 81.4±13.4 81.4±14.1 84.2±13.8 85.0±13.0 88.8±13.1 
β-END (fmol/mL) 203±54.0 278±84.0 110±42.0 225±73.0 230±92.0 
Cortisol (nmol/L) 364±34.0 367±38.0 332±47.0 421±81.0 421±81.0 
IL-6 (pg/mL) 1.46±0.32 1.56±0.56 1.20±0.24 0.83±0.10 0.82±0.10 
VAS (mm) 22.1±3.71 23.1±5.73 21.2±5.22 21.1±5.27 20.0±4.46 
“Owls”         
25(OH)D3 (nmol/L) 70.5±11.5 72.2±11.2 74.0±11.5 76.3±10.5 79.5±11.0 
β-END (fmol/mL) 203±60.0 179±63.0 266±68.0 250±76.0 253±66.0 
Cortisol (nmol/L) 413±34.0 507±59.0 522±43.0 464±38.0 467±48.0 
IL-6 (pg/mL) 0.83±0.21 0.67±0.10 0.80±0.12 0.63±0.09 0.72±0.07 
VAS (mm) 34.1±7.85 27.5±4.80 26.7±5.40 24.9±6.89 22.3±6.27 
      
Absolute values are given as mean±SEM.    
 
 
 
